-
Bristol-Myers To Pay Largest Fee In Biotech History For Nektar Cancer Drug
Forbes | Bristol-Myers Squibb says it will pay a record $1.85 billion to Nektar Therapeutics, a small biotech startup, for rights to its experimental cancer drug, codenamed NKTR-214. Nektar will book 65% of global profits on the drug, should it reach the market, with Bristol getting the other 35%.
Feb 14, 2018
-
The Pistoia Alliance Launches User Experience For Life Sciences Toolkit
Bio-IT World Brief | The Pistoia Alliance has today announced the launch of the User Experience for Life Sciences Toolkit, to help life science companies improve UX in line with other global industries.
Feb 13, 2018
-
Reliable Standards: A Necessity For Genomic Data
Bio-IT World Contributed Commentary | As the field of genomics grows, it is imperative that we develop reliable, high-quality data standards with which to gauge accuracy and completeness.
Feb 12, 2018
-
23andMe Launches The Global Genetics Project
23andMe Blog | 23andMe launches a Global Genetics Project recruiting thousands of individuals with recent heritage from dozens of countries in Africa, Oceania, Asia, and the Americas to improve research in underrepresented populations, and reveal new insights into patterns of human migration and genetic diversity.
Feb 8, 2018
-
This New Company Wants To Sequence Your Genome And Let You Share It On A Blockchain
MIT Technology Review | A new startup from George Church, Nebula Genomics, says it will sequence your genome, secure it using a blockchain, and let you earn cryptocurrency by sharing it with pharma companies.
Feb 7, 2018
-
Scientific Data Doctoring: Could Blockchain Technology Help Stamp It Out?
Bio-IT World Contributed Commentary | Blockchain technology has emerged as a technology that could reduce data falsification in a publicly visible, traceable, perpetual and immutable fashion, and thus help to rebuild trust in science.
Feb 7, 2018
-
Oxford Nanopore Outlook 2018
Omics! Omics! Blog | Keith Robison gives his thoughts on the recent publication of the human genome sequencing paper focusing on Oxford Nanopore.
Feb 7, 2018
-
Charles River Makes Investments In High-Throughput Screening Infrastructure
Bio-IT World Brief | Charles River announced a new agreement which grants Charles River commercial access to AstraZeneca’s high-throughput screening and compound management infrastructure.
Feb 6, 2018
-
Sequencing Human Genome With Pocket-Sized “Nanopore” Device
NIH Director's Blog | A report in Nature Biotechnology highlights the latest advance in DNA sequencing: the sequencing and assembly of a human genome using a pocket-sized device.
Feb 6, 2018
-
Gut Microbes Combine To Cause Colon Cancer, Study Suggests
The New York Times | Two types of bacteria common in the gut may accelerate the growth of tumors, suggesting new possibilities for diagnosis and prevention.
Feb 5, 2018
-
Despite Doubters, Moderna Raises $500 Million, Is Now Worth $7 Billion
Forbes | Moderna Therapeutics, a biotechnology firm that is developing drugs that work on a genetic messaging system that is essentially to all living cells, has raised $500 million from a group of new and current investors.
Feb 2, 2018
-
IBM Brings V100 GPUs To Its Cloud
TOP500 | The popularity of NVIDIA's Tesla V100 GPUs got another boost this week with IBM's announcement that it has added them to its cloud offerings.
Feb 2, 2018
-
Certara Acquires BaseCase, A Life Sciences Data Visualization Company
Bio-IT World Brief | Certara today announced that it has acquired BaseCase, a data visualization software as a service company who has extensive Health Economics and Outcomes Research expertise and is actively working in the area of market access.
Feb 1, 2018
-
The Doctor Responsible For Gene Therapy’s Greatest Setback Is Sounding A New Alarm
MIT Technology Review | Toxic effects seen in animals raise questions about new gene therapies for children.
Jan 31, 2018
-
Transpacific Biotech Startup Combines Asian Investors And Some Seriously Trendy Science Out Of MIT
ENDPOINTS NEWS | Engine Biosciences plans to integrate AI and machine learning with hands-on lab work in drug development to create a whole new kind of drug development platform.
Jan 31, 2018
-
A Biopharma Innovator's Wish List For President Trump
STAT | In his first State of the Union address, the CEO of Alnylam Pharmaceuticals would like to hear President Trump address five key issues to foster the culture of innovation in the pharmaceutical industry.
Jan 30, 2018
-
Will America Yield Its Position As The World’s Leader In Science And Technology?
BostonGlobe | For the first time since World War II, America's primacy in science and technology is in jeopardy. Choices that the country makes today will determine whether it continues to reap the rewards that come from being at the cutting edge.
Jan 29, 2018
-
Oxford Nanopore MinION Used To Produce Most Complete Human Genome
Bio-IT World A paper published today in Nature Biotechnology, reports Oxford Nanopore sequencing resulting in the most complete human genome ever assembled with a single technology.
Jan 29, 2018
-
Genedata, Congenica, Nanome, And More: News From January 2018
Bio-IT World | January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Genedata, Congenica, Nanome, and more.
Jan 29, 2018
-
Video: The Hyve Discusses Health Data Research Infrastructures, IoT In Webinar
Bio-IT World | In a recent webinar, Kees Bochove of The Hyve delved into consent, GDPR, the healthcare professional’s role in infrastructure, FAIR principles, open source solutions, the future of wearables, and much more.
Jan 26, 2018